Nouscom's Series B Round

Nouscom raised a round of funding on November 06, 2017.

Nouscom has developed technology that focuses on viral vectors and oncolytic viruses, which infect and kill tumor cells and stimulate an immune response against cancer cells throughout the body. The c…

Articles about Nouscom's Series B Round: